An unprecedented $3 million was raised to support lupus research through two fundraising efforts, the 2016 Walk with Us to Cure Lupus program and the TCS NYC Marathon team, the Lupus Research Alliance announced. In total, the national Walk program has raised about $33.5 million since its 2002 inception, the Lupus Research Alliance said in a press…
Mallinckrodt Pharmaceuticals announced the enrollment of the first patients in the company’s Phase 4 clinical trial of H.P. Acthar Gel (repository corticotropin injection) for the treatment of systemic lupus erythematosus (SLE) patients with persistently active disease. The randomized and double-blind study (NCT02953821) will assess the effectiveness of the gel against…
Bilingual groups providing support and education to systemic lupus erythematosus (SLE) patients and their family members  — people who live in minority U.S. neighborhoods — considerably help them to manage and cope with the disease, a survey shows. The findings were recently presented at the recent American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) annual…
Anthera Pharmaceuticals’ CHABLIS-SC1 Phase 3 clinical trial of its investigational therapy blisibimod did not meet its primary endpoint. After 52 weeks of treatment, there was no statistically significant clinical benefit for systemic lupus erythematosus (SLE) patients treated with the drug compared to placebo-treated patients. Blisibimod acts by blocking BAFF, a…
Neovacs announced that it has enrolled the first patient in the United States in its expanded, Phase 2b global clinical trial evaluating IFNalpha-Kinoid,  a therapeutic vaccine, to treat systemic lupus erythematosus (SLE). The trial (NCT02665364), which began in September 2015, has attracted the interest of American clinical centers and autoimmune…
Merck KGaA announced that it will present two posters showing positive clinical data for its drug candidate atacicept, a recombinant fusion protein for the treatment of systemic lupus erythematosus (SLE). The presentations will take place at the 2016 American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Annual Meeting in Washington, D.C., which opens on Friday and runs through…
An independent Data Safety Monitoring Board (DSMB) established by Biotest has recommended the company begin part 2 of its Phase 2a clinical study assessing BT-063, a monoclonal antibody for the treatment of systemic lupus erythematosus (SLE). The DSMB recommendation follows positive interim results. Study 990 (NCT02554019) is a Phase 2…
The Oklahoma Medical Research Foundation (OMRF), an independent non-profit biomedical research institute, will enter a new research collaboration with Eisai, an oncology and neurology-oriented pharmaceutical, to study the genetics of lupus. In lupus patients, the immune system becomes unbalanced and attacks the body’s own tissues. This might lead…
The Lupus Foundation of America (LFA) announced the launch of its latest crowdfunding campaign to raise money for lupus research: The “Cut it Out” 14-day challenge to end lupus. A diagnosis of lupus can be life-altering. Many patients are seriously affected by their disrupted lifestyle following diagnosis. The name…
Georgia on my mind … So much has happened in the last two weeks I have no idea of where to even start. If you’ve been following along with my many misadventures this summer, you would know that I went road tripping, island hopping, visited with friends both far…